Brooks Macdonald Group (BRK)

Sector:

Financials

Index:

FTSE AIM 50

1,600.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 2,300.00
  • 52 Week Low: 1,300.00
  • Currency: UK Pounds
  • Shares Issued: 16.13m
  • Volume: 3,158
  • Market Cap: £258.03m
  • RiskGrade: 196

Monday broker round-up

By Caoimhe Toman

Date: Monday 08 Oct 2018

LONDON (ShareCast) - (Sharecast News) - Mediclinic International: Investec upgrades to buy with a target price of 448p.
Pearson: Berenberg reiterates sell with a target price of 550p.

Astrazeneca: Deutsche Bank reiterates buy with a target price of 6,400p.

Glaxosmithkline: Deutsche Bank reiterates hold with a target price of 1,525p.

MONDI: Deutsche Bank reiterates buy with a target price of 2,600p.

WPP Group: Deutsche Bank reiterates hold with a target price of 1,430p.

Tullow Oil: Morgan Stanley reiterates overweight with a target price of 355p.

Brooks Macdonald: Numis downgrades to add with a target price of 2,210p.

UNITE Group: Numis reiterates hold with a target price of 900p.

Reach: Numis reiterates buy with a target price of 208p.

Rathbones: Numis upgrades to add with a target price of 2,730p.

Centamin: Numis reiterates buy with a target price of 130p.

Mitie: Canaccord reiterates buy with a target price of 300p.

Ferguson: Berenberg reiterates buy with a target price of 7,000p.

Johnson Matthey: Morgan Stanley reiterates overweight with a target price of 3,900p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

BRK Market Data

Currency UK Pounds
Share Price 1,600.00p
Change Today 5.00p
% Change 0.31 %
52 Week High 2,300.00
52 Week Low 1,300.00
Volume 3,158
Shares Issued 16.13m
Market Cap £258.03m
RiskGrade 196

BRK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.04% below the market average49.04% below the market average49.04% below the market average49.04% below the market average49.04% below the market average
74.05% below the sector average74.05% below the sector average74.05% below the sector average74.05% below the sector average74.05% below the sector average
Price Trend
23.05% below the market average23.05% below the market average23.05% below the market average23.05% below the market average23.05% below the market average
16.9% below the sector average16.9% below the sector average16.9% below the sector average16.9% below the sector average16.9% below the sector average
Income
46.45% above the market average46.45% above the market average46.45% above the market average46.45% above the market average46.45% above the market average
22.5% below the sector average22.5% below the sector average22.5% below the sector average22.5% below the sector average22.5% below the sector average
Growth
1.95% above the market average1.95% above the market average1.95% above the market average1.95% above the market average1.95% above the market average
13.56% below the sector average13.56% below the sector average13.56% below the sector average13.56% below the sector average13.56% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BRK Dividends

  Latest Previous
  Interim Final
Ex-Div 26-Mar-20 26-Sep-19
Paid 24-Apr-20 08-Nov-19
Amount 21.00p 32.00p

Trades for 16-Jul-2020

Time Volume / Share Price
16:29 2 @ 1,640.00p
16:29 145 @ 1,640.00p
16:28 4 @ 1,640.00p
16:24 500 @ 1,625.00p
16:17 57 @ 1,635.00p

BRK Key Personnel

CEO Caroline Connellan
Chair Alan Thomas Carruthers

Top of Page